Malignant Ascites
1 competing product in clinical development for Malignant Ascites.
Pipeline by Phase
Phase 1/21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| liposomal irinotecan monotherapy + liposomal irinotecan monotherapy + Liposomal Irinotecan + rmhTNF-NC + Liposomal Irinotecan + Bevacizumab | CSPC Pharmaceutical Group Limited | Phase 1/2 | Recruiting | 40 |